Overview
Corporate health screenings along the Ghodbunder Road belt have been increasingly including PSA testing.Read moreShow less
And the result is a growing number of men from Hiranandani Estate, Manpada, and Brahmand receiving PSA results that require specialist interpretation. An elevated PSA on a health screening report can generate significant anxiety; in most cases, the elevation has a benign explanation, but a proportion will have prostate cancer that requires immediate specialist management. Mercurrey Hospital at Kapurbawdi junction — 10–15 minutes from most Ghodbunder Road residential communities — is the most practically accessible specialist prostate cancer assessment option for this corridor. Dr. Harshawardhan Godbole FRCS, Cancer Lead, interprets PSA findings in full clinical context and applies mpMRI as the pre-biopsy investigation standard.
What to know
Prostate Cancer Treatment at Mercurrey Hospital, Kapurbawdi
Prostate cancer is the most common cancer in men in the UK and among the top three in India.Read moreShow less
PSA blood test, digital rectal examination (DRE), multiparametric MRI (mpMRI), and transperineal biopsy confirm diagnosis and Gleason/ISUP grade. Active surveillance is appropriate for low-risk disease. Radical prostatectomy (laparoscopic) and radical radiotherapy with hormone therapy treat high-risk localised disease. Hormone therapy (ADT) with chemotherapy or novel hormonal agents manages advanced and metastatic disease through specialist MDT. Dr. Godbole is Cancer Lead and MDT Lead at North Middlesex University Hospital NHS Trust.
Health Screening PSA Results in the Ghodbunder Road Corporate Community
The proliferation of corporate health screening along the Ghodbunder Road belt has created a specific clinical scenario: executives and professionals in their 50s receiving PSA results in health screening reports with no clinical context — no DRE, no age-specific reference range, and no indication of what the next step should be.Read moreShow less
HRG Urology at Mercurrey Hospital is specifically equipped to address this: interpreting the PSA in the context of age, prostate size (estimated from DRE), PSA velocity where prior values are available, and PSA density — then determining whether mpMRI is indicated or whether reassurance is appropriate.
Avoiding Over-Investigation and Under-Investigation in Prostate Cancer
The dual risk in prostate cancer management is treating cancers that would never have caused harm (over-treatment) and missing cancers that require treatment (under-investigation).Read moreShow less
At Mercurrey Hospital, Dr. Godbole's approach follows European Association of Urology (EAU) guidelines — which recommend mpMRI for men with elevated PSA before any biopsy, risk-stratified active surveillance for low-risk Gleason 6 cancers, and curative treatment for intermediate and high-risk disease. This evidence-based, guideline-adherent approach avoids both under-treating significant cancers and over-treating clinically insignificant ones.
Travel and Parking Guide – Mercurrey Hospital, Kapurbawdi
High Street Mall Junction, Samata Nagar, Kapurbawdi, Majiwada 400607.Read moreShow less
From Hiranandani Estate: 10–12 minutes. From Manpada: 15 minutes. From Brahmand: 20 minutes. Auto-rickshaws know "Kapurbawdi High Street Mall." Street parking at the junction.
Why Mercurrey
Nearby areas
MajiwadaKapurbawdiGhodbunder RoadManpadaHiranandani Estate
Mercurrey Hospital serves prostate cancer patients from Majiwada, Kapurbawdi, Ghodbunder Road, Manpada, Hiranandani Estate, Brahmand, Owale, Kolshet, and Pokhran Road.Read moreShow less
Patients from Mira Road and Bhayander seeking the closest Cancer Lead urology on the western Thane axis also attend.
Questions
My corporate health screening showed a PSA of 5.2 in Hiranandani Estate — what should I do?
A PSA of 5.2 requires specialist clinical interpretation — not just comparison to a generic reference range. Whether this level is concerning depends on your age (PSA rises with age as a normal finding), your prostate size (estimated by DRE), and whether any prior PSA values are available for comparison. At Mercurrey Hospital, Dr. Godbole provides this full clinical interpretation. Call +91 88280 71522 for an appointment.
What is the PIRADS scoring system for prostate MRI and what does my report mean?
PIRADS (Prostate Imaging-Reporting and Data System) scores MRI lesions from 1 (very low probability of significant cancer) to 5 (very high probability). PIRADS 1 and 2 are reassuring — no biopsy needed in most cases. PIRADS 3 is equivocal — clinical factors determine whether biopsy is warranted. PIRADS 4 and 5 warrant targeted biopsy of the specific lesion. Dr. Godbole's assessment at Mercurrey Hospital interprets your specific PIRADS score in the context of your PSA and DRE findings.
Is transperineal prostate biopsy available through HRG Urology at Mercurrey Hospital, Majiwada?
Transperineal prostate biopsy — performed through the perineal skin under local or general anaesthesia — has a significantly lower infection risk than the traditional transrectal approach (TRUS biopsy) and is increasingly recommended as the standard approach in international guidelines. Dr. Godbole's team arranges transperineal biopsy where clinically indicated for patients assessed through HRG Urology at Mercurrey Hospital.
What is the difference between radical prostatectomy and radiotherapy for prostate cancer?
Both radical prostatectomy (surgical removal of the prostate) and radical radiotherapy (high-dose radiation to the prostate) achieve equivalent cancer control for localised prostate cancer. The differences are in side effect profiles: surgery has higher initial urinary incontinence and erectile dysfunction rates that improve over 12–18 months; radiotherapy has lower initial side effects but higher rates of late bowel and urinary complications. The choice between them depends on tumour characteristics, patient age and fitness, and patient preference. Dr. Godbole presents both options with their specific evidence at the Mercurrey Hospital consultation.
Can prostate cancer spread to bones, and how is this assessed?
Yes. Bone is the most common site of prostate cancer metastasis. Bone metastases cause pain, fracture risk, and are a principal cause of prostate cancer-related mortality in advanced disease. Bone scan or PSMA PET-CT (where available) is used to assess for bone metastases in intermediate and high-risk localised disease and in recurrent or advanced disease. Dr. Godbole's staging pathway at Mercurrey Hospital includes appropriate imaging for bone involvement where indicated by risk stratification.
